Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.450NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.334NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.589NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.335NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.169NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.43NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.42NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AE.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
D.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.447NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.110.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.180NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.155NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.92NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.145NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.120NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.77NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AE.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.504NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.447EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.110.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.180EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.155EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.92EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.145EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.120EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.504EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
AE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.201EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.221EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.410EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.411EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.109EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.361EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.417EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-13011.1South Korea
B.1.1.139EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.508EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.94EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.463EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.357EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.318EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.557EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.119EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.160EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used